Teijin Limited v. Hetero USA Inc.
1:14-cv-00166
Overview
Parties
Defendant
Hetero Labs Ltd. Operating Company
Represented By
2 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Hetero USA Inc. Operating Company
Represented By
5 Attorneys ListedHeyman Enerio Gattuso & Hirzel LLP
300 Delaware Avenue, Suite 200, Wilmington, DE 19801
Plaintiff
Takeda Pharmaceuticals USA Inc. Operating Company
Represented By
5 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Teijin Pharma Limited NPE (University / Research)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Teijin Limited NPE (University / Research)
Represented By
2 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 3 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | Asserted | Asserted Patent | View Official Patent → |
| 🇯🇵 Japan | Japan Counterpart | View Official Patent → | |
| 🌐 PCT International (WIPO) | PCT World Application | View Official Patent → |
Teijin Limited v. Macleods Pharmaceuticals Ltd.
Teijin Limited v. Unimark Remedies Ltd.
Teijin Limited v. Prinston Pharmaceutical Inc.
Teijin Limited v. Roxane Laboratories Inc.
Teijin Limited v. Zydus Pharmaceuticals USA Inc.
Teijin Limited v. Alembic Pharmaceuticals Limited
Teijin Limited v. Dr. Reddy's Laboratories Ltd.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US6225474
Polymorphs of 2-(3-cyano-4-isobutyloxyphenyl)-4-methyl-5-thiazolecarboxylic acid and method of producing the same
|
Filed: 1999-06-18
Issued: 2001-05-01
|
Expired (Term Ended)
Expires: 2019-06-18
|
|
|
US7361676
Solid preparation containing single crystal form
|
Filed: 2003-03-28
Issued: 2008-04-22
|
Expired (Term Ended)
+346d PTA
Expires: 2024-03-08
|
|
|
US8372872
Methods for concomitant treatment of theophylline and febuxostat
|
Filed: 2011-11-14
Issued: 2013-02-12
|
Active (5.0 yrs remaining)
Expires: 2031-11-14
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, injunctive relief is barred.
Standard Statutory Term — No obviousness-type double patenting noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
1
Dispositive
0
Granted
0
Denied
0
Pending / Review
0
Motions by Category
Key Dispositive Motions & Rulings